Department of Vascular Surgery, Union Hospital, Fujian Medical University, Fuzhou, Fujian, China.
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231200851. doi: 10.1177/10760296231200851.
To evaluate the safety and efficacy of percutaneous thrombectomy for treating postpartum iliofemoral vein thrombosis.
A retrospective analysis was performed on patients with continuous postpartum acute symptomatic iliofemoral deep vein thrombosis who were treated in our center, including all patients who underwent pharmacomechanical thrombolysis (PMT) or only catheter-directed thrombolysis (CDT) (study group), and patients that received simple anticoagulation treatment (control group). We evaluated the incidence of lower extremity postthrombotic syndrome, recanalization rate of lower extremity veins, and complications in the study and control groups.
Overall, 72 postpartum women were included in this study, including the PMT combined with CDT group (14 cases, 15 limbs), CDT alone group (26 cases, 27 limbs), and anticoagulant therapy alone group (32 cases, 34 limbs). The thrombectomy group completed the treatment with a technical success rate of 100%, and no serious bleeding complications occurred. The patency rate of lower limb veins in the thrombectomy group was 85.09 ± 16.51% after treatment and 82.60 ± 21.45% after 1 year. At the 1-year follow-up, the Villalta score in the study group was lower (1.90 ± 2.45 vs 8.50 ± 5.33, < .001), and the incidence of postthrombotic syndrome was significantly different between the groups (17.50% in the study group vs 68.75% in the anticoagulant group, < .001).
Lower extremity venous thrombectomy is a safe and effective treatment for postpartum iliofemoral venous thrombosis. It can improve the patency rate of lower extremity veins and reduce the incidence of postthrombotic syndrome compared with anticoagulation alone.
评估经皮血栓切除术治疗产后髂股静脉血栓形成的安全性和有效性。
对在我院治疗的连续产后急性症状性髂股深静脉血栓形成患者进行回顾性分析,包括所有接受药物机械溶栓(PMT)或仅导管直接溶栓(CDT)的患者(研究组)和仅接受单纯抗凝治疗的患者(对照组)。我们评估了研究组和对照组下肢血栓后综合征的发生率、下肢静脉再通率和并发症。
共有 72 例产后女性纳入本研究,包括 PMT 联合 CDT 组(14 例,15 条肢体)、CDT 组(26 例,27 条肢体)和单独抗凝治疗组(32 例,34 条肢体)。血栓切除术组治疗技术成功率为 100%,未发生严重出血并发症。下肢静脉通畅率在血栓切除术组治疗后为 85.09±16.51%,治疗 1 年后为 82.60±21.45%。在 1 年随访时,研究组的 Villalta 评分较低(1.90±2.45 比 8.50±5.33, < .001),且血栓后综合征的发生率在组间有显著差异(研究组 17.50%比抗凝组 68.75%, < .001)。
下肢静脉血栓切除术是治疗产后髂股静脉血栓形成的一种安全有效的方法。与单纯抗凝治疗相比,它可以提高下肢静脉通畅率,降低血栓后综合征的发生率。